Patent: 5,605,690
✉ Email this page to a colleague
Summary for Patent: 5,605,690
Title: | Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor |
Abstract: | A method for treating TNF-dependent inflammatory diseases in a mammal by administering a TNF antagonist, such as soluble TNFR. |
Inventor(s): | Jacobs; Cindy A. (Seattle, WA), Smith; Craig A. (Seattle, WA) |
Assignee: | Immunex Corporation (Seattle, WA) |
Application Number: | 08/385,229 |
Patent Claims: | see list of patent claims |
Details for Patent 5,605,690
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2014-02-25 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2014-02-25 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2014-02-25 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 02/01/2007 | ⤷ Try a Trial | 2014-02-25 |
Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | 09/14/2017 | ⤷ Try a Trial | 2014-02-25 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | ⤷ Try a Trial | 2014-02-25 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,605,690
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 131871 | ⤷ Try a Trial |
Austria | 242322 | ⤷ Try a Trial |
Australia | 3970293 | ⤷ Try a Trial |
Australia | 4920993 | ⤷ Try a Trial |
Australia | 6178190 | ⤷ Try a Trial |
Australia | 630497 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |